Exercise heart rates in patients with hypertrophic cardiomyopathy

Hong-Chang Luo1, Veronica L Dimaano2, Jackelyn M Kembro2

  • 1Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Division of Cardiology, Johns Hopkins University, Baltimore, Maryland.

Insights

Patients with hypertrophic cardiomyopathy (HC) show impaired exercise heart rate response, linked to disease severity. Interventions like myectomy may improve chronotropic response but not heart rate recovery, suggesting these are not independent high-risk markers.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Hypertrophic cardiomyopathy (HC) affects cardiac function and can lead to arrhythmias.
  • Exercise heart rate (HR) dynamics, including chronotropic response (CR) and heart rate recovery (HRR), are crucial indicators of cardiovascular health.

Purpose of the Study:

  • To investigate the exercise HR profile in patients with HC.
  • To determine the relationship between CR, HRR, cardiac function, and arrhythmias in HC.
  • To assess the impact of septal myectomy on CR and HRR in HC patients.

Main Methods:

  • Treadmill exercise testing was performed in 273 HC patients and 95 controls.
  • Chronotropic response (CR) and heart rate recovery (HRR) were calculated.
  • Diastolic function (E/e') and left atrial volume index were assessed.

Main Results:

  • HC patients exhibited higher prevalence of chronotropic incompetence and lower HRR (1-5 min) compared to controls.
  • Exercise capacity, diastolic function, and left atrial volume index correlated with HRR1min and CR in HC.
  • Septal myectomy reduced chronotropic incompetence but did not alter HRR1min.

Conclusions:

  • Impaired CR and HRR1min in HC are associated with advanced disease, not independent high-risk markers.
  • Improving CR through medication, myectomy, or pacing may enhance exercise capacity in HC patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
3.5K